Partner Content Partner Content Beyond Immunotherapies Latest innovations emerging from immunotherapy research
Partner Content Partner Content Managing Multi-Arm Studies in an Evolving Immuno-Oncology La... Collaborate with CROs and sites to help minimize risks
Partner Content Partner Content Orphan medicines, advances, access and affordability LONDON, UNITED KINGDOM, April 19th 2017:
Views & Analysis The top three benefits to commercial outsourcing in pharma In the face of continuing industrial and technological progress – and the resulting imperative for business agility – commercial outsourcing has come of age not a moment too soon.
White Papers Sponsored Seizing the potential of commercial outsourcing in the pharm... The power and potential of outsourcing has long been recognised as a core enabler of business growth.
Views & Analysis Getting it right: the UK’s pathway for 2017 The implications for global pharma HQs and what the UK needs to do.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
